AROUND LAB NEWS

13/01/2026

TRIO.BAS Microbial Air Sampler
The reliable solution for microbial air monitoring in the most critical environments.

Designed to ensure precision, repeatability, and regulatory compliance, TRIO.BAS offers portable and bench-top solutions ideal for:
🔹 Laboratories
🔹 Cleanrooms
🔹 Pharmaceutical industry
🔹 Food & Beverage facilities

TRIO.BAS precision engineering delivers consistent performance even in the most demanding environments, supporting quality control and process safety.

👉 Learn more: www.triobas.com

29/12/2025

TRIO.SETTLE: the smart standard for passive air monitoring 💨🧫

In controlled contamination environments, every detail matters.
This is why ORUM INTERNATIONAL presents TRIO.SETTLE, the AISI 316 stainless-steel stand designed to standardize settle plate exposure even under unidirectional airflow, as shown in the product visual with tilted plate and integrated digital timer.

✅ Articulated stainless-steel structure to easily adjust plate angle and reduce turbulence
✅ Fully autoclavable, easy to sanitize and highly resistant
✅ Bench-top and floor versions (code 367/368), compatible with 90 mm Petri dishes
✅ Digital timer for reproducible exposure times
✅ Validated according to EN 17141, ideal for pharmaceutical cleanrooms, RABS, isolators, filling lines, laboratories and vaccine production

Combined with TRIO.BAS™ active air samplers, TRIO.SETTLE offers a complete and compliant view of the microbiological quality of air in your critical environments.

🔗 Find out more about TRIO.SETTLE and how to optimize your environmental monitoring program: www.triobas.com

21/11/2025

Milan, Capital of Environmental Monitoring: Orum International's Global Meeting a Success

MILAN – The three-day TRIO.BAS™ International Distributors Meeting (November 19–21, 2025) concluded today within the historic setting of Villa Cella. Organized by ORUM INTERNATIONAL, the event saw key partners and distributors from around the world converge in Milan to define new strategies in the field of contamination control.

The meeting represented a crucial juncture for the microbiological air monitoring sector. Through intensive training sessions and technical roundtables, the company presented the latest evolutions of TRIO.BAS™ technology, confirming the central role of "Made in Italy" in ensuring high safety standards for the Pharmaceutical industry, Food & Beverage, and the Healthcare sector.

More than just a corporate event, the gathering solidified the strengthening of ORUM’s global network. Proceedings focused on the sharing of international case histories and the analysis of future market challenges, with the specific goal of standardizing and elevating the quality of technical support offered to end customers on a global scale.

With the conclusion of the proceedings, the company charts the course for 2026, empowered by a renewed synergy with its international partners.

🔗 Read more: https://ow.ly/6uQc50XvCU3

19/11/2025

🧬 Pasquale Pasquini – 19 novembre 1901
Ricordiamo oggi Pasquale Pasquini, biologo e zoologo italiano nato il 19 novembre 1901.
Pur essendo specializzato in zoologia, le sue ricerche hanno attraversato i confini disciplinari, toccando anche il campo della microbiologia. Il suo lavoro ha arricchito la comprensione dei meccanismi biologici animali, dimostrando come la scienza non conosca barriere tra i saperi. 🧫🦠

13/11/2025

🧬 Luigi Gorini – 13 novembre 1903
Luigi Gorini, nato a Milano il 13 novembre 1903, è stato una figura chiave nella microbiologia del XX secolo. Dopo essersi laureato in medicina, ha intrapreso una brillante carriera nella ricerca, approfondendo i meccanismi di stabilizzazione degli enzimi batterici.
Trasferitosi negli Stati Uniti, ha lavorato alla New York University e ha insegnato microbiologia e genetica molecolare alla Harvard Medical School. Le sue ricerche sulla regolazione genica in Escherichia coli e sulla funzione dei ribosomi hanno lasciato un segno duraturo nella scienza. 🌍🔬

05/11/2025

👁️ Visual Inspection Workshop – Berlino (11 novembre 2025)

Workshop intensivo a Berlino per esperti VI: best practice, automatizzazione, normative e confronto tra operatori. Include sessioni pratiche e networking.

Info e registrazione 👉 https://ow.ly/YwsZ50WsHNU

Dear Colleagues, Please be kindly invited to join this one-day meeting on visual inspection (VI) that will be held in Berlin, Germany on 11 November 2025.

20/10/2025

🧬 October 20 — Howard Florey (1898–1968) & Ernst Chain (1906–1979)
The team that turned penicillin into a “miracle” drug.

When Alexander Fleming observed penicillin (1928) he couldn’t purify it, produce enough of it, or demonstrate its clinical potential; for over a decade it remained a laboratory curiosity. At Oxford, Howard Florey (pathologist) and Ernst Chain (biochemist) decided to start from scratch: between 1939–1941 they solved the purification problem, characterized the substance, and obtained quantities sufficient for testing. The results were striking: in mouse models with lethal infections, 100% survival with penicillin, 0% without. In 1941 the first human patient, police officer Albert Alexander, showed dramatic improvement—until supplies ran out. Subsequent cases (mostly children) recovered.

One major obstacle remained: mass production. Florey flew to the United States (1941), where, with the USDA laboratory in Peoria, Illinois, and pharmaceutical companies (Pfizer, Merck, Squibb), they moved to deep-tank fermentation. A phenomenal strain, Penicillium chrysogenum, was found on a moldy cantaloupe from the Peoria market, and the medium was optimized with corn steep liquor (an abundant industrial by-product). From there the escalation:
• 1942: penicillin sufficient for ~10 patients
• 1943: supplies for the Allied military
• 1944: 2.3 million doses ready for D-Day
• 1945: mass civilian availability

In 1945 the Nobel Prize went to Fleming, Florey, and Chain. Less known, but crucial, was the work of Norman Heatley, who devised key extraction methods and equipment to scale the process. They chose not to patent penicillin—a decision that accelerated global dissemination and saved millions of lives, while forgoing enormous financial returns.

The impact? A paradigm shift: infections once often fatal became treatable; surgery was transformed; life expectancy rose. Most importantly, a model was born: from discovery to purification, from preclinical testing to the clinic, all the way to industrial scale-up. Every modern antibiotic, vaccine, or biological therapy still follows the pipeline that Florey & Chain built for penicillin.

19/10/2025

🧫 October 19 — Selman Waksman (1888–1973)
The man who industrialized antibiotic discovery.

While Fleming’s penicillin arose by chance, Waksman chose the systematic route. A soil microbiologist at Rutgers, he realized that earth teems with microorganisms engaged in chemical warfare: each produces molecules to inhibit competitors. From this came his program: isolate actinomycetes (especially Streptomyces), screen them for antimicrobial activity, purify the active compounds, and test them. Hypothesis-driven, industrial-scale science.

In 1943, after thousands of isolates, graduate student Albert Schatz identified Streptomyces griseus, which produced streptomycin, the first effective treatment for tuberculosis. It was a watershed: sanatoriums began to empty, and the possibility emerged of taming bacterial diseases that had been intractable.

As early as 1942, Waksman had coined the term “antibiotic” to denote microbially produced substances that kill or inhibit other microorganisms—a precise word that entered everyday language. His method became an industry template:
1. Collect soil samples from diverse environments
2. Isolate actinomycetes
3. Screen for antimicrobial activity
4. Purify and characterize active compounds
5. Test toxicity and efficacy

From this gold rush emerged iconic classes: chloramphenicol, tetracyclines, erythromycin, and from Waksman’s own lab neomycin. His group described over 20 antibiotics (including actinomycin, the first with anticancer activity, and candicidin).

The 1952 Nobel Prize recognized streptomycin; controversy followed over Schatz, excluded from the award but later compensated and acknowledged as co-discoverer. Beyond credit, Waksman’s deepest insight was ecological: antibiotics are evolutionary weapons. Where competition is fiercest, natural chemistry is richer—and resistance mechanisms co-evolve.

The legacy is double: a pipeline that has saved millions of lives, and a warning of a post-antibiotic era if use remains indiscriminate. Today’s challenge is to return to the lesson of the soil: seek new environments, new niches, new producers—and use these gifts with greater wisdom.

vr5

19/10/2025

🧬 Francesco Blasi – 19 ottobre 1937
Oggi ricordiamo Francesco Blasi, biologo italiano nato il 19 ottobre 1937.
Sebbene conosciuto soprattutto per i suoi studi in biologia, le sue ricerche hanno avuto possibile impatto anche nel campo della microbiologia. Un esempio di come la scienza sia spesso un territorio di confine, dove discipline diverse si incontrano e si arricchiscono a vicenda. 🔬🇮🇹

18/10/2025

🧬 October 18 — Kary Mullis (1944–2019)
The inventor of PCR: the in-tube DNA amplification that changed diagnostics, forensics, and research.

On a Friday night in 1983 along California’s Highway 128, Mullis had an insight: use two primers flanking the DNA region of interest, a DNA polymerase, and repeated temperature cycles to double the target sequence each time. Thus was born the Polymerase Chain Reaction.

How it works (elegance in three steps):
1. Denaturation (~95 °C) — DNA strands separate.
2. Annealing (~50–65 °C) — primers bind the target.
3. Extension (~72 °C) — the polymerase copies the DNA.
Each cycle doubles the target: after ~30 cycles → ~2³⁰ copies (over a billion) from a trace starting amount.

The Taq breakthrough: at first, fresh enzyme had to be added each cycle because heat inactivated it. Using Taq polymerase (from the thermophilic bacterium Thermus aquaticus, hot springs) made PCR automated and practical: the enzyme survives thermal cycling and thermocyclers became universal instruments.

Why it’s a revolution:
• Diagnostics: rapid detection of pathogens (HIV, TB, SARS-CoV-2), tumor variants, prenatal testing.
• Forensics & paleogenomics: genetic fingerprints from tiny samples, paternity testing, ancient DNA.
• Research & biotech: cloning, sequencing (through the Human Genome Project), evolutionary studies, contamination control, food safety, environment.

In 1993 Mullis received the Nobel Prize in Chemistry (with Michael Smith for site-directed mutagenesis): lightning-fast recognition just ten years after the idea. Debates persist over credit for Taq and automation, but the impact is indisputable: PCR democratized molecular biology, bringing sophisticated analyses everywhere.

A brilliant and controversial figure, Mullis held disputable positions (HIV/AIDS, climate, etc.). That doesn’t change the fact that PCR is among the cornerstone inventions of the 20th century: from Neanderthal genomes to pandemic RT-PCR swabs, every epidemiological curve and molecular diagnosis bears the imprint of that 1983 insight.

From a spark at the wheel to billions of copies in a test tube: that is the power of PCR.

17/10/2025

🧬 October 17 — Carl Woese (1928–2012)
The scientist who redrew the tree of life.

For over a century we classified organisms by form, metabolism, and habitat. Woese changed the method: he compared 16S rRNA sequences, a “molecular chronometer” because ribosomes are essential (they aren’t lost), rRNA evolves slowly, and it can be compared across all living beings. Differences accumulate like the ticks of a clock and reveal deep relationships.

The discovery that shocked biology (1977): studying methanogenic microorganisms from cow rumen and marine sediments, Woese didn’t find “odd bacteria” but a third great branch of life. Those “archaebacteria” were as distant from Bacteria as Eukaryotes are: the domain Archaea was born.

The three-domain model replaced the old five kingdoms:
1. Bacteria — the “classic” bacteria (peptidoglycan, etc.);
2. Archaea — only superficially bacteria-like, but with unique membrane lipids, distinct cell wall chemistry, and different molecular machinery;
3. Eukarya — organisms with a nucleus (animals, plants, fungi, protists).
Crucial point: Archaea and Eukarya are more closely related to each other than either is to Bacteria.

Not just extremophiles: yes, hydrothermal vents and salt lakes—but also oceans, soils, and even the human microbiota. Archaea are key players in the carbon and nitrogen cycles and make up a significant share of marine plankton.

The taxonomic revolution: molecular phylogeny replaces morphology; 16S/18S becomes the gold standard for identifying microbes; metagenomics reveals an immense uncultivable biodiversity. The “tree” expands and, for prokaryotes, often looks like a network.

Woese met resistance: too radical for the establishment. But as thousands of sequences accumulated, his three-domain tree was confirmed and became a foundation of modern systematics. The deeper lesson? Sequences tell ancestry better than appearance. Convergent evolution can fool the eye; DNA does not.

Every microbiome study, every phylogenetic tree, every metagenomic survey rests on Woese’s work. And it reminds us that plants, animals, and fungi are only a small twig on a tree dominated by an invisible—and wonderful—microbial diversity.

16/10/2025

🧬 October 16 — François Jacob (1920–2013) & Jacques Monod (1910–1976)
The architects of gene regulation.

How do bacteria “know” when to produce the enzymes to digest lactose? At the Pasteur Institute in 1961, Jacob and Monod answered with a model as simple as it was profound: the lac operon.
The players: the genes lacZ–lacY–lacA (enzymes for lactose metabolism); an operator (the DNA switch); a repressor that binds the operator and blocks transcription; an inducer (lactose/allolactose) that inactivates the repressor.
The logic:
• No lactose → the repressor occupies the operator → genes OFF.
• Lactose present → the inducer binds the repressor → the repressor releases the operator → genes ON.

Here lies the revolution: genes are not always on; they respond to the environment via molecular switches. Jacob and Monod coined “operon”: a cluster of genes under unified control, transcribed as a single unit. This economical design lets bacteria regulate entire metabolic pathways with one signal. From it flow general principles: there are regulatory genes encoding regulatory proteins; regulation can be negative (repressors) or positive (activators); small molecules modulate protein function through allostery.

Together with Sydney Brenner, their work helped establish mRNA, the unstable messenger that carries instructions from DNA to ribosomes, completing the central dogma: DNA → RNA → Protein. In 1965 Jacob, Monod, and André Lwoff received the Nobel Prize “for their discoveries concerning genetic control of enzyme and virus synthesis.”

The impact goes far beyond bacteria: the same principles explain how a single genome yields hundreds of cell types, how embryonic development unfolds, how hormones reshape gene expression, and how cancer often arises from regulatory failures. The lac operon was a Rosetta Stone: it showed that genes don’t just “exist,” they are choreographed in space and time by evolution.